Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

BACKGROUND: In the current study we used contrast-enhanced T1 subtraction maps to test whether early changes in enhancing tumor volume are prognostic for overall survival (OS) in newly diagnosed glioblastoma (GBM) patients treated with chemoradiation with or without bevacizumab (BV). METHODS: Seven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ellingson, Benjamin M, Abrey, Lauren E, Garcia, Josep, Chinot, Olivier, Wick, Wolfgang, Saran, Frank, Nishikawa, Ryo, Henriksson, Roger, Mason, Warren P, Harris, Robert J, Leu, Kevin, Woodworth, Davis C, Mehta, Arnav, Raymond, Catalina, Chakhoyan, Ararat, Pope, Whitney B, Cloughesy, Timothy F
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178278/
https://ncbi.nlm.nih.gov/pubmed/29897562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados